WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Events
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Speaking Engagements

12.10.25

Colorado BioScience Association Thought Leadership Series: Finding Success in a Challenging Funding Environment
Wilson Sonsini, in partnership with EY and Colorado BioScience Association, invites you to an in-depth program bringing together leaders, investors, and innovators from across Colorado’s life sciences ecosystem discussing our current funding environment.  
Speaking Engagements

9.16.25

Swissnex Startup Pitch Night
We're happy to support Swissnex Startup Pitch Night, where the latest technologies from Switzerland’s most innovative health tech start-ups are presented. Matt Meyer will be speaking.
Speaking Engagements

9.10.25

From Lab to Launch: Navigating IVD/LDT Reimbursement, Regulatory, and Investment Hurdles
On September 10, 2025, Wilson Sonsini's Eva Yin, Partner, and Matthew Meyer, Chief Business Advisor, will participate in the “From Lab to Launch” webinar, hosted by GenoSan. Eva will present on FDA regulatory pathways and compliance considerations for diagnostics companies entering the U.S. market. Matthew will offer insights on how life sciences startups can effectively pitch to venture capital firms, drawing on his experience advising diagnostics and biopharma companies. The webinar is designed for innovators, entrepreneurs and industry executives preparing to bring new diagnostic technologies to market. For more information about the event, you can visit the event website.
Affiliated Programs

6.11.25

Innosphere & Wilson Sonsini Lunch and Learn: Best Practices When Pitching to Life Science Investors and Industry Partners
Join us this week with Innosphere for a focused discussion on Best Practices When Pitching to Life Science Investors and Industry Partners. Whether you are an emerging biopharma company or have a breakthrough idea for a digital health app, understanding the nuances of the life science venture capital environment is critical in setting your company up for success. Through this session, you will learn about the different types of life science investors, how to prepare for an outreach, how to develop a “killer” pitch deck, and gain insights on the partnering process. Learn more about the lunch & learn, featuring firm partner Brent Fassett and chief business advisor Matthew Meyer here.
Speaking Engagements

5.14.25

Best Practices When Pitching to VCs
This session is designed to equip entrepreneurs with the skills and strategies needed to deliver compelling pitches that captivate audiences and attract potential partners. Participants will gain insights into crafting impactful narratives, structuring pitches for maximum engagement, and leveraging support to secure investment opportunities.
WSGR Events

4.24.25

The New Administration's First 90 Days – Impacts on Fundraising in the Life Sciences Industry
Our experienced panel will discuss the first 90 days of the new administration and its impact on fundraising and investment in the life sciences sector.
Affiliated Programs

3.13.25

2025 Entrepreneur and Investor Life Sciences Summit (E&I Summit), presented by BioUtah
Wilson Sonsini is looking forward to the 2025 Entrepreneur & Investor Life Sciences Summit (E&I Summit), presented by BioUtah and the University of Utah Technology Licensing Office. Now in its 12th year, the E&I Summit convenes Utah’s life sciences leaders, entrepreneurs, and the investor community.
Affiliated Programs

2.26.25

PBSS Workshop: Demystifying Biopharma Business Development: Understanding the Process and Thriving
Wilson Sonsini is proud to sponsor the Pharmaceutical & BioScience Society (PBSS).
Affiliated Programs

10.30.24

Stanford SPARK Business Panel Discussion
Wilson Sonsini patents and innovations attorney Rona Lamiquiz and Chief Business Advisory Officer for Life Sciences Matthew Meyer will speak on a SPARK business panel, providing attendees with an opportunity to meet and ask questions of VC/venture arm partners, business strategists, patent attorneys, and an Office of Technology Licensing expert. Fellow panelists include Cheryl Cathey, Senior Licensing and Strategic Alliance Manager at Stanford OTL; Kristina Kitko, Director of Venture Science at Lilly; Josh Lichtman, CSO and Co-Founder of TCG Labs Soleil; and Srini Akkaraju, Founder and Managing Partner at Samsara BioCapital.
Speaking Engagements

5.29.24

Swissnex Session: Successfully Expanding into the U.S. Life Science Market
Matthew Meyer will lead the session: "Successfully Expanding into the U.S. Life Science Market."
Affiliated Programs

5.16.24

Yale Ventures How to Pitch for High Engagement
The virtual info session, "How to Pitch for High Engagement," sponsored by Wilson Sonsini Goodrich & Rosati, is designed to equip entrepreneurs heading to the 2024 Yale Innovation Summit with the skills and strategies needed to deliver compelling pitches that captivate audiences and attract potential partners. Participants will gain insights into crafting impactful narratives, structuring pitches for maximum engagement, and leveraging support to secure investment opportunities.
Affiliated Programs

10.27.23

North Carolina Biotech Center – Wilson Sonsini Life Science Bootcamp
Wilson Sonsini is pleased to partner with the North Carolina Biotechnology Center to host a Life Science Bootcamp. Join us on October 27 for an event that will highlight practical insights into crucial legal and business matters for life science entrepreneurs. Attendees will gain expertise in key areas such as IP and licensing strategy, market-oriented patent and trade secret approaches, competitor analysis, in-licensing of enabling technologies, and collaborative IP structures.
  • 1
  • 2
  • 3
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.